Data Foundry

Drug recalls 2026

Testosterone — Class II drug recall D-0324-2026

Ongoing recall by F.H. INVESTMENTS, Inc. (dba Asteria Health), reported 2026-02-18, distributed nationwide. Presence of Foreign substance - potential presence of metal particulate matter

Recall numberD-0324-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmF.H. INVESTMENTS, Inc. (dba Asteria Health), Birmingham, AL, United States
Recall initiated2026-01-26
Classified2026-02-11
Reported by FDA2026-02-18
DistributedNationwide (US)
Quantity194,336 pellets
Reason classesspecification failure
NDC79559-1200-43
Lot numbers251000127, 251000128, 251000133, 251000134, 251000135, 251000138, 251000139, 251000140, 251000141, 251000147, 251000148, 251000149, 251000156, 251000157, 251000164, 251000165, 251000166, 251000169, 251000171, 251000172, 251000180
Expiration dates2026-06-03, 2026-06-05, 2026-06-16, 2026-06-25, 2026-07-28, 2026-08-08, 2026-08-22, 2026-08-29, 2026-09-03, 2026-09-19

Product

Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.

Reason for recall

Presence of Foreign substance - potential presence of metal particulate matter

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0324-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.